Victor Tong, Jr. has served on Aardvark's Board since May 2024. He is a Managing Director at Decheng Capital, where he has worked since the firm's inception in 2012, focusing on biotechnology and medical technology investments in China and the United States. He was previously a Principal at Bay City Capital and a member of the healthcare investment banking division at Morgan Stanley. He has served on the board of CG Oncology, Inc. (Nasdaq: CGON) since July 2023 and on the boards of several private biotechnology companies. Mr. Tong received his B.A. in Molecular and Cell Biology and his B.S. in Business Administration from the University of California, Berkeley. He serves on Aardvark's Nominating and Corporate Governance and Audit Committees.